Navigation Links
Pain drug can kill resistant tuberculosis
Date:9/10/2012

NEW YORK (September 10, 2012) -- An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant tuberculosis in the laboratory -- a feat few currently approved TB drugs can do, and resistance to those is spreading.

Their findings, published online by the journal PNAS, point to a potential new therapy for the more than 500,000 people worldwide whose TB has become resistant to standard drug treatments. But the researchers worry that the effective drug, oxyphenbutazone, may never be tested in TB clinical trials.

Weill Cornell's Dr. Carl Nathan and his research team found what they call the "completely surprising" ability of oxyphenbutazone to kill drug resistant TB after testing thousands of approved drugs against the bacteria. This repurposing of agents already on the market can lead to quicker testing for new uses.

"This agent might help save lives if there was a way to test it in TB patients," says Dr. Nathan. Oxyphenbutazone went on the market as a patented drug for arthritis-like pain in the early 1950s, and lost its patent and market dominance by the 1970s.

"It is difficult today to launch clinical studies on a medication that is so outdated in the United States, that it is mainly used here in veterinary medicine to ease pain," says the study's senior author, Dr. Nathan, chairman of the Department of Microbiology and Immunology, the R.A. Rees Pritchett Professor of Microbiology, and the director of The Abby and Howard Milstein Program in the Chemical Biology of Infectious Disease at Weill Cornell. "No drug firm will pay for clinical trials if they don't expect to make a profit on the agent. And that would be the case for an off-patent drug that people can buy over the counter for pain in most of the world."

He adds that oxyphenbutazone, best
'/>"/>

Contact: Lauren Woods
law2014@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Molecule shows effectiveness against drug-resistant myeloma
2. Alarming Rise Seen in Drug-Resistant Tuberculosis
3. Possible therapy for tamoxifen resistant breast cancer identified
4. Renal sympathetic denervation improves physical and mental health in resistant hypertension
5. Renal denervation treats resistant hypertension in real world patient populations
6. African Chimps Carry Drug-Resistant, Human-Linked Staph
7. Gonorrhea Resistant to All But One Antibiotic: CDC
8. Treating drug resistant cancer through targeted inhibition of sphingosine kinase
9. Computational analysis identifies drugs to treat drug-resistant breast cancer
10. A new route for tackling treatment-resistant prostate cancer
11. Abuse-Resistant Oxycontin May Be Driving Addicts to Heroin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Final Cut Pro X plugin developers have announced a new ... , “ProBlue 5k is a compilation of anamorphic flares that ... Christina Austin, CEO of Pixel Film Studios. “Blurring the line ... changer.” , ProBlue 5k is the ultimate Ultra High Definition ... footage compilation of over 100 anamorphic flares can be applied ...
(Date:9/17/2014)... Las Vegas, NV (PRWEB) September 17, 2014 ... by Dr. Dan Ritchie and Dr. Cody Sipe that is ... quality of life and longevity has caught the attention of ... ask most people in their 50s, 60s, or even 70s ... quality of life on a day-to-day basis, they would probably ...
(Date:9/17/2014)... the ends of chromosomes could hold the key to a ... skin cancer according to new research from the University ... new genetic risk factor for melanoma. , It is well ... of those most at risk of developing melanoma. For example, ... they burn more easily. , It now appears that another ...
(Date:9/17/2014)... In Pretrial Order #139 (Scheduling of Discovery ... would be beneficial in this [MDL].” Accordingly, the court ... end of December,” the order further provides, “the court ... , “The plain import of this order is ... to be discussed as these cases progress toward trial,” ...
(Date:9/17/2014)... blood test that measures DNA from a prostate cancer ... the state of a man,s disease, a new study ... could reveal when treatment for advanced prostate cancer ... researchers suggested. "Our study showed that a steroid ... often initially very effective started to activate harmful mutations ...
Breaking Medicine News(10 mins):Health News:A New Plugin Entitled ProBlue 5k Was Released Today from Pixel Film Studios Exclusively for Final Cut Pro X 2Health News:Functional Fitness Solution: Review Exposes Dr. Dan Ritchie and Dr. Cody Sipe’s Guide to Everyday Fitness for Longevity 2Health News:Chromosome buffers hold key to better melanoma understanding 2Health News:Transvaginal Mesh Lawsuit News: New Order in C.R. Bard MDL Sets Schedule of Conferences for September to December, the Rottenstein Law Group LLP Reports 2Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2
... SAGE Launch Clinical Psychological Science ,Association for Psychological ... Angeles, CA (April 23, 2012) The Association for ... Clinical Psychological Science , a new peer-reviewed journal focused ... venue for cutting-edge research across a wide range of ...
... Guy, M.D., professor of ophthalmology at Bascom Palmer Eye ... Medicine, has pioneered a novel technological treatment for Leber ... causes rapid, permanent, and bilateral loss of vision in ... Genetic mutations in the mitochondria (part of the ...
... 23 (HealthDay News) -- Teen drivers and passengers are more likely ... belt laws, often promoted as "click it or ticket" laws, a ... and ticket drivers solely for not wearing a seat belt. Under ... are stopped for other reasons, such as speeding. Primary seat ...
... The Global Cardiovascular Disease Taskforce called on the 11,000 ... cardiovascular disease (CVD) community at large, to support the ... disease (NCD) mortality by 25 per cent by 2025. ... from the world,s largest CVD organizations including the American ...
... Hispanic lung cancer patients seem to live longer than ... Cancer , a peer-reviewed journal of the American Cancer ... types of cancer, certain yet-to-be-defined genetic and/or environmental factors ... studies that look at ethnic and racial disparities in ...
... Health (NIH) scientists and their colleagues in China have ... called sasX , which plays a pivotal role ... in most of Asia. Senior author Michael Otto, Ph.D., ... says these findings illustrate at the molecular level how ...
Cached Medicine News:Health News:Association for Psychological Science, SAGE launch Clinical Psychological Science 2Health News:Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder 2Health News:Stricter Seat Belt Laws Get Teens to Buckle Up, Study Shows 2Health News:Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology 2Health News:Hispanic lung cancer patients tend to live longer than blacks and whites 2Health News:NIH scientists link quickly spreading gene to Asian MRSA epidemic 2
(Date:9/17/2014)... , Sept. 17, 2014 The ... the last decade due to the recession, ... and technological advancements. This BCC Research report ... segments of the ambulance and emergency medical ... blood and hemorrhage control devices, equipment used ...
(Date:9/17/2014)... BURLINGTON, Mass. , Sept. 17, 2014 ... Crohn,s disease/ulcerative colitis (CD/UC) patients eligible for ... currently receive a biologic. Surveyed gastroenterologists cite ... main reason for low penetration rates, followed ... CD and UC patients receiving biologics, Janssen ...
(Date:9/17/2014)... NEW YORK and SAN JOSE, Calif. ... Systems has been named as a laureate of The ... recognized for applying technology to benefit humanity and spark global ... Museum of Innovation, and presented by Applied Materials, Inc., selected ... Award category. Photo - http://photos.prnewswire.com/prnh/20140917/146680 ...
Breaking Medicine Technology:Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3Gradian Health Systems Named A 2014 Laureate of The Tech Awards 2Gradian Health Systems Named A 2014 Laureate of The Tech Awards 3
... Mass., April 29, 2012  Haemonetics Corporation (NYSE: ... definitive agreement to acquire the business assets of Hemerus ... for the collection of whole blood, and processing and ... clinical trials and has submitted a New Drug Application ...
... Calif., April 27, 2012  Ultra Clean Holdings, ...  of critical subsystems, for the semiconductor capital equipment, ... announced that Clarence Granger, Chairman and Chief Executive ... address the Jefferies 2012 Global Technology, Media & ...
Cached Medicine Technology:Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC 2Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC 3Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC 4
Tracheal Suction Latex Rubber Catheters - Funnel End...
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip....
KCIs KinAir IV combines Advanced Pressure Relief Therapy with a manual wound care turn to provide optimum skin care and patient,positioning....
... The Paradigm LD400 FT is an affordable ... exam time by at least 40%. It has ... It features rapid setup and easy two-button operation ... friendly. The LD 400 FT is the workhorse ...
Medicine Products: